ALTS vs III

ALTS exhibits severe financial distress signals, with a Piotroski F-Score of 2/9 indicating poor operational and financial health. The company's Altman Z-Score is unavailable, but its negative ROA (-1.71%), negative operating margin (-218.34%), and extremely low current ratio (0.80) suggest high bankruptcy risk. Despite strong revenue growth (53.3% YoY), profitability remains elusive, and the stock trades at a steep Price/Sales of 6.85, far above its low Price/Book of 0.11. The 52-week price range ($1.08–$10.95) and 5-year decline of 82.8% reflect deep investor skepticism, despite a single 'strong_buy' analyst recommendation.

III presents a stable financial health profile with a Piotroski F-Score of 6/9, but is fundamentally undermined by poor valuation and negative momentum. The stock trades at a significant premium to both its Graham Number ($2.91) and Intrinsic Value ($1.33), while exhibiting a bearish technical trend (0/100). Critical concerns include a nearly unsustainable dividend payout ratio of 94.74% and aggressive insider selling by the CEO and major shareholders. Despite a low PEG ratio and optimistic analyst targets, the combination of declining earnings growth and insider divestment suggests limited upside.